Spectrum Pharmaceuticals, Inc. et al v. Amneal Pharmaceuticals LLC, No. 2:2015cv00139 - Document 37 (D. Nev. 2016)

Court Description: FINAL JUDGMENT in favor of Amneal that claims 1 and 2 of the '829 patent are invalid, and claims 3, 4, and 5-14 of the ' 829 patent are not infringed by ANDA No. 207547 as if fully tried and adjudicated.. Signed by Judge James C. Mahan on 6/9/16. (Copies have been distributed pursuant to the NEF - JC)
Download PDF
Spectrum Pharmaceuticals, Inc. et al v. Amneal Pharmaceuticals LLC Doc. 37 1 2 3 4 UNITED STATES DISTRICT COURT 5 THE DISTRICT OF NEVADA 6 SPECTRUM PHARMACEUTICALS, INC. and UNIVERSITY OF STRATHCLYDE, Case No.: 2:15-cv-00139-JCM-NJK 7 Plaintiffs, 8 [PROPOSED] ORDER vs. 2300 WEST SAHARA AVENUE, SUITE 1200 • LAS VEGAS, NEVADA 89102 PHONE (702) 873-4100 • FAX (702) 873-9966 McDONALD • CARANO • WILSON LLP 9 AMNEAL PHARMACEUTICALS LLC 10 Defendant. 11 12 WHEREAS, on January 23, 2015, Plaintiffs Spectrum Pharmaceuticals, Inc. and 13 University of Strathclyde (collectively, “Plaintiffs”) commenced this action against Amneal 14 Pharmaceuticals, Inc. (“Amneal”), alleging infringement of U.S. Patent No. 6,500,829 (“the 15 ’829 patent”) under 35 U.S.C. § 271(a), (b), (c), and (e)(2)(A) (ECF No. 1); WHEREAS Plaintiffs and Amneal have jointly stipulated to final judgment in this 16 17 action in accordance with the Stipulation for Entry of Final Judgment. 18 NOW, THEREFORE, IT IS HEREBY ORDERED AS FOLLOWS: 19 Judgment is entered in favor of Amneal that claims 1 and 2 of the ’829 patent are 20 invalid, and claims 3, 4, and 5-14 of the ’829 patent are not infringed by ANDA No. 207547 as 21 if fully tried and adjudicated. 22 IT IS SO ORDERED: 23 UNITED STATES DISTRICT JUDGE June 9, 2016 DATED: 24 25 26 27 360402 28 Page 1 of 1 Dockets.Justia.com